Merit Medical Systems, Inc. Announces Executive Changes
October 22, 2021 at 04:37 pm EDT
Share
Effective as of October 19, 2021, Merit Medical Systems, Inc., through a wholly-owned subsidiary, terminated the employment of Justin Lampropoulos, President, Europe, Middle East and Africa.
Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.
MERIT MEDICAL SYSTEMS, INC. 
